Ascendis Pharma is a dynamic, fast-growing global biopharmaceutical company with locations in Denmark, Europe, and the United States. Today, we're advancing programs in Endocrinology Rare Disease and Oncology.Here at Ascendis, we pride ourselves on exceptional science, visionary leadership, and skilled and passionate colleagues.Guided by our core values of Patients, Science, and Passion, we use our TransCon® drug development platform to fulfill our mission of developing new and potentially best-in-class therapies to address unmet medical needs.Our culture fosters a place where skilled, adaptable, and highly resourceful professionals can truly make their mark. We offer a dynamic workplace for employees to grow and develop their skills.Serving as the driver of the development of the global strategic publication plan for one or more rare disease therapeutic areas, the Associate Director of Global Scientific Publication Planning oversees the planning, execution, and amplification of scientific publications, including abstracts, posters, oral presentations, manuscripts, and publication extenders. The Associate Director will collaborate cross-functionally to understand the medical communications needs across the organization and will represent the Publication Planning function across departments.First preference is for someone who can work hybrid from Princeton, NJ but remote candidates may be considered. This role will report to the Director, Global Head of Publication Planning.Key Responsibilities Demonstrate a command of therapeutic areas and expertise with assigned products in growth hormone deficiency, hypoparathyroidism, achondroplasia, and new therapeutic areas in development Lead cross-functional teams to drive the development and rationale for the publication plan and strategic objectives for individual medical communications tactics. Interface with external experts (e.g., key opinion leaders, clinical trial investigators, and other healthcare professionals) and internal stakeholders (e.g., Clinical, Statistics, Medical Affairs,) to ensure publications address gaps and unmet needs and incorporate the latest data and expert perspectives. Oversee the tactical execution of the publication plan, ensuring the development of high-quality, scientifically accurate, and timely publications. Develop and maintain expert knowledge of Ascendis publication policies and procedures as well as industry regulations and guidelines to ensure publications are pursued and executed compliantly, following industry best practices. Contribute to department initiatives/activities to improve publications practices and processes. Stay current on industry and company requirements and best practices as they relate to scientific publications. Ensure publications are pursued and executed compliantly, following industry standards. May write original content for publications, as needed. RequirementsPhD or PharmD required. Professional credentials/certification (e.g., CMPP) a plus.8+ years in medical or scientific publications within the pharmaceutical industry required.Knowledge of publications best practices (ICMJE, GPP2022) required.Ability to navigate complex data and rapidly incorporate relevant insights into medical communications.Demonstrated leadership capacity, including success working collaboratively in cross-functional settings.Experience managing medical or scientific writers/vendors.Experience managing budgets.Estimated compensation $170-190K/year DOEBenefits 401(k) plan with company match Medical, dental, and vision plans Company-offered Life and Accidental Death & Dismemberment (AD&D) insurance Company-provided short and long-term disability benefits Unique offerings of Pet Insurance and Legal Insurance Employee Assistance Program Employee Discounts Professional Development Health Saving Account (HSA) Flexible Spending Accounts Various incentive compensation plans Accident, Critical Illness, and Hospital Indemnity Insurance Mental Health resources Paid leave benefits for new parents A note to recruiters:We do not allow external search party solicitation. Presentation of candidates without written permission from the Ascendis Pharma Inc Human Resources team (specifically from: Talent Acquisition Partner or Human Resources Director) is not allowed. If this occurs your ownership of these candidates will not be acknowledged.
Ascendis Pharma is a dynamic, fast-growing global biopharmaceutical company with locations in Denmark, Europe, and the United States. Today, we're advancing programs in Endocrinology Rare Disease and Oncology.
Here at Ascendis, we pride ourselves on exceptional science, visionary leadership, and skilled and passionate colleagues.
Guided by our core values of Patients, Science, and Passion, we use our TransCon® drug development platform to fulfill our mission of developing new and potentially best-in-class therapies to address unmet medical needs.
Our culture fosters a place where skilled, adaptable, and highly resourceful professionals can truly make their mark. We offer a dynamic workplace for employees to grow and develop their skills.
Serving as the driver of the development of the global strategic publication plan for one or more rare disease therapeutic areas, the Associate Director of Global Scientific Publication Planning oversees the planning, execution, and amplification of scientific publications, including abstracts, posters, oral presentations, manuscripts, and publication extenders. The Associate Director will collaborate cross-functionally to understand the medical communications needs across the organization and will represent the Publication Planning function across departments.
First preference is for someone who can work hybrid from Princeton, NJ but remote candidates may be considered. This role will report to the Director, Global Head of Publication Planning.
Key Responsibilities
- Demonstrate a command of therapeutic areas and expertise with assigned products in growth hormone deficiency, hypoparathyroidism, achondroplasia, and new therapeutic areas in development
- Lead cross-functional teams to drive the development and rationale for the publication plan and strategic objectives for individual medical communications tactics.
- Interface with external experts (e.g., key opinion leaders, clinical trial investigators, and other healthcare professionals) and internal stakeholders (e.g., Clinical, Statistics, Medical Affairs,) to ensure publications address gaps and unmet needs and incorporate the latest data and expert perspectives.
- Oversee the tactical execution of the publication plan, ensuring the development of high-quality, scientifically accurate, and timely publications.
- Develop and maintain expert knowledge of Ascendis publication policies and procedures as well as industry regulations and guidelines to ensure publications are pursued and executed compliantly, following industry best practices.
- Contribute to department initiatives/activities to improve publications practices and processes. Stay current on industry and company requirements and best practices as they relate to scientific publications.
- Ensure publications are pursued and executed compliantly, following industry standards.
- May write original content for publications, as needed.
Requirements
- PhD or PharmD required. Professional credentials/certification (e.g., CMPP) a plus.
- 8+ years in medical or scientific publications within the pharmaceutical industry required.
- Knowledge of publications best practices (ICMJE, GPP2022) required.
- Ability to navigate complex data and rapidly incorporate relevant insights into medical communications.
- Demonstrated leadership capacity, including success working collaboratively in cross-functional settings.
- Experience managing medical or scientific writers/vendors.
- Experience managing budgets.
Estimated compensation $170-190K/year DOE
Benefits
- 401(k) plan with company match
- Medical, dental, and vision plans
- Company-offered Life and Accidental Death & Dismemberment (AD&D) insurance
- Company-provided short and long-term disability benefits
- Unique offerings of Pet Insurance and Legal Insurance
- Employee Assistance Program
- Employee Discounts
- Professional Development
- Health Saving Account (HSA)
- Flexible Spending Accounts
- Various incentive compensation plans
- Accident, Critical Illness, and Hospital Indemnity Insurance
- Mental Health resources
- Paid leave benefits for new parents
A note to recruiters:
We do not allow external search party solicitation. Presentation of candidates without written permission from the Ascendis Pharma Inc Human Resources team (specifically from: Talent Acquisition Partner or Human Resources Director) is not allowed. If this occurs your ownership of these candidates will not be acknowledged.
Founded in Copenhagen, Denmark in 2007, Ascendis Pharma is applying its innovative platform technology to build a leading, fully integrated biopharma company focused on making a meaningful difference in patients’ lives. Guided by our core values of patients, science and passion, we utilize our innovative TransCon™ technology platform to create new and potentially best-in-class therapies.Today, we’re advancing programs in Endocrinology Rare Disease, Oncology, and Ophthalmology. We currently have five product candidates in clinical development: three in Endocrinology Rare Disease and two in Oncology. In addition, Ascendis recently announced new pre-clinical programs in Ophthalmology. We are a dynamic, growing biopharma company with headquarters in Copenhagen and additional offices and research facilities in Germany (Heidelberg, Munich, and Berlin) and the United States (Palo Alto, California, and Princeton, New Jersey).
Founded in Copenhagen, Denmark in 2007, Ascendis Pharma is applying its innovative platform technology to build a leading, fully integrated biopharma company focused on making a meaningful difference in patients’ lives. Guided by our core values of patients, science and passion, we utilize our innovative TransCon™ technology platform to create new and potentially best-in-class therapies.
Today, we’re advancing programs in Endocrinology Rare Disease, Oncology, and Ophthalmology. We currently have five product candidates in clinical development: three in Endocrinology Rare Disease and two in Oncology. In addition, Ascendis recently announced new pre-clinical programs in Ophthalmology.
We are a dynamic, growing biopharma company with headquarters in Copenhagen and additional offices and research facilities in Germany (Heidelberg, Munich, and Berlin) and the United States (Palo Alto, California, and Princeton, New Jersey).
